FDA Approves AstraZeneca’s Imfinzi Combination
The FDA approved AstraZeneca’s Imfinzi combination with enfortumab.
Related stories
Frehemgo Approved in the EU for Haemophilia A
The EU approved Frehemgo for haemophilia A, with monthly, every-two-weeks or weekly dosing options.
M impact | REGULATION | Nov 13, 2026, 08:23 PM UTC
FDA Approves AstraZeneca’s Perioperative Imfinzi Regimen for Bladder Cancer
AstraZeneca says Imfinzi with neoadjuvant enfortumab vedotin was approved in the US for patients with muscle-invasive bladder cancer.
M impact | REGULATION | Nov 13, 2026, 08:05 PM UTC
FAA Grants SpaceX License for Starship’s 15th Texas Flight Friday
The FAA granted SpaceX a launch license for Starship’s 15th flight from Texas, scheduled for Friday.
M impact | REGULATION | Nov 13, 2026, 07:37 PM UTC
SEC Proposes Executive and Director Compensation Disclosure Reforms
Washington D.C., Nov. 13, 2026 The Securities and Exchange Commission today proposed rule amendments to make its executive and director compensation disclosure requirements more pr
H impact | REGULATION | Nov 13, 2026, 06:54 PM UTC
Supreme Court to Weigh Trump Asylum Restrictions
The Supreme Court will consider Trump administration restrictions on asylum at the US-Mexico border, according to the administration.
L impact | REGULATION | Nov 13, 2026, 06:49 PM UTC
Supreme Court to Hear Robinhood Bid to Avoid IPO Lawsuit
M impact | REGULATION | Nov 13, 2026, 06:45 PM UTC